News from NORD

Foundation Fighting Blindness Opens USH2A Natural History Study


 

The first patient has been enrolled in a four-year, 120-person study of the rate of disease progression and severity in people with mutations in the USH2A gene, a mutation that causes blindness and in some cases the loss of both vision and hearing. Additional information is available here.

Recommended Reading

CREST syndrome and PBC are often associated
MDedge Internal Medicine
Immunologic testing is key to diagnosing autoimmune blistering diseases
MDedge Internal Medicine
Join the National Organization for Rare Disorders and the University of Massachusetts for Two Upcoming CME-Accredited Events
MDedge Internal Medicine
Rare Disease Film Festival Is Planned
MDedge Internal Medicine
NORD Outlines Recommendations for Health Care Reform in Letter to Congressional Leadership
MDedge Internal Medicine
Alport Syndrome Research Funding Is Awarded
MDedge Internal Medicine
Aplastic Anemia and MDS International Foundation Plans Regional Patient/Family Conference
MDedge Internal Medicine
Global CMTC/OVM Conference to Take Place in The Netherlands
MDedge Internal Medicine
Conan O’Brien to Host Congenital Hyperinsulinism International Event
MDedge Internal Medicine
CurePSP International Research Symposium to Take Place in San Francisco
MDedge Internal Medicine